Indirect dopamine agonists effects on despair test: Dissociation from hyperactivity

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 235-239

  Vaugeois, Jean Marie ^a   Pouhé, Dieudonné ^a   Zuccaro, Florence ^a   Costentin, Jean ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

behavioral despair test; D1, D2 dopamine receptors; indirect dopamine agonists; mice; motor activity

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLALLYL)PIPERAZINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DRUG ANTAGONISM; FORCED SWIMMING TEST; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029928843     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02131-0     Document Type: Conference Paper

References (32)

1. Allison, K.; Ivanova, S.; Greenshaw, A. J. Behavioral response to SKF 38393 and quinpirole following chronic antidepressant treatment. Eur. J. Pharmacol. 277:139-144; 1995.
2. 2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacol. Biochem. Behav. 48:43-46; 1994.
3. Bonnet, J.-J.; Costentin, J. GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivo. Eur. J. Pharmacol. 121:199-209; 1986.
4. Borsini, F.; Meli, A. Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacology (Berlin) 94:147-160; 1988.
5. 1, receptors reduces immobility time of rats in the forced swimming test: Implication for antidepressant activity. Eur. J. Pharmacol. 148:301-307; 1988.
6. Bourin, M. Is it possible to predict the activity of a new antide-pressant in animals with simple psychopharmacological tests? Fundam. Clin. Pharmacol. 4:49-64; 1990.
7. Brown, A. S.; Gershon, S. Dopamine and depression. J. Neural Transm. (Gen. Sect.) 91:75-109; 1993.
8. Browne, R. G. Effects of antidepressants and anticholinergics in a mouse "behavioral despair test. Eur. J. Pharmacol. 58:331-334; 1979.
9. Bulach, C.; Doaré, L.; Massari, B.; Simon, P. Effet "antidépresseur" de 3 monoamines endogènes: Profils psychopharmacologiques de la noradrénaline, de l'octopamine et de la phényléthy-lamine. J. Pharmacol. (Paris) 15:1-15; 1984.
10. 2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology (Berlin) 105:335-339; 1991.
11. Colonna, L.; Petit, M.; Lépine, J. P. Bromocriptine in affective disorders. J. Affect. Dis. 1:173-177; 1979.
12. 1 receptor agonists in the behavioral despair animal model of depression. Eur. J. Pharmacol. 262:107-111; 1994.
13. 2 receptors in depression measured with single photon emission computed tomography. Biol. Psychiatry 35:128-132; 1994.
14. Duterte-Boucher, D.; Leclère, J.-F.; Panissaud, C.; Costentin, J. Acute effects of direct dopamine agonists in the mouse behavioral despair test. Eur. J. Pharmacol. 154:185-190; 1988.
15. Duterte-Boucher, D.; Kamenka, J.-M.; Costentin, J. Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioral tests involving central catecholaminergic transmissions. Psychopharmacology (Berlin) 101:344-353; 1990.
16. Fischer, J. F.; Cho, A. K. Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208:203-209; 1979.
17. 1 dopamine receptors in mediating the antidepressant effect of imipramine. Pharmacol. Biochem. Behav. 50:147-151; 1995.
18. Geoffroy, M.; Christensen, A. V. Psychomotor stimulants vs. antidepressants in the learned helplessness model of depression. Drug Dev. Res. 29:48-55; 1993.
19. Iorio, L. C.; Barnett, A.; Leitz, F. H.; Houser, V. P.; Korduba, C. A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:462-468; 1983.
20. 2 behavioral actions. Eur. J. Pharmacol. 101:159-160; 1984.
21. 2 antagonists SCH 23390 and metoclopramide. Eur. J. Pharmacol. 108:305-308; 1985.
22. Mouret, J.; Lemoine, P.; Minuit, M. P. Marqueurs polygraphiques, cliniques et thérapeutiques des dépressions dopamine dé pendantes. C. R. Acad. Sc. Paris 305:301-306; 1987.
23. 1 receptors by chronic imipramine is species specific. Pharmacol. Biochem. Behav. 39:769-771; 1991.
24. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berlin) 115:441-446; 1994.
25. Porsolt, R. D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229:327-336; 1977.
26. Porsolt, R. D.; Bertin, A.; Blavet, N.; Deniel, M.; Jalfre, M. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57:201-210; 1979.
27. Post, R. M.; Gerner, R. H.; Carman, J. S.; Gillin, J. C.; Jimerson, D. C.; Goodwin, F. K.; Bunney, W. E. Effects of a dopamine agonist piribedil in depressed patients. Arch. Gen. Psychiatry 35:609-615; 1978.
28. Schlechter, J. M.; Butcher, L. L. Blockade by pimozide of (+)-amphetamine-induced hyperkinesia in mice. J. Pharm. Pharmacol. 24:408-409; 1972.
29. Seeman, P. Brain dopamine receptors. Pharmacol. Rev. 32:229-313; 1980.
30. 1 dopamine receptor agonists potential antidepressants? Pharmacol. Res. Commun. 20:1121-1122; 1988.
31. Thiébot, M. H.; Martin, P.; Puech, A. J. Animal behavioral studies in the evaluation of antidepressant drugs. Br. J. Psychiatry 160(Suppl. 15):44-50; 1992.
32. Willner, P. Animal models of depression: An overview. Pharmacol. Ther. 45:425-455; 1990.